Literature DB >> 17942559

Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent.

Sonia Molina1, Valerie Castet, Lydiane Pichard-Garcia, Czeslaw Wychowski, Eliane Meurs, Jean-Marc Pascussi, Camille Sureau, Jean-Michel Fabre, Antonio Sacunha, Dominique Larrey, Jean Dubuisson, Joliette Coste, Jane McKeating, Patrick Maurel, Chantal Fournier-Wirth.   

Abstract

Hepatitis C virus-positive serum (HCVser, genotypes 1a to 3a) or HCV cell culture (JFH1/HCVcc) infection of primary normal human hepatocytes was assessed by measuring intracellular HCV RNA strands. Anti-CD81 antibodies and siRNA-CD81 silencing markedly inhibited (>90%) HCVser infection irrespective of HCV genotype, viral load, or liver donor, while hCD81-large intracellular loop (LEL) had no effect. However, JFH1/HCVcc infection of hepatocytes was modestly inhibited (40 to 60%) by both hCD81-LEL and anti-CD81 antibodies. In conclusion, CD81 is involved in HCVser infection of human hepatocytes, and comparative studies of HCVser versus JFH1/HCVcc infection of human hepatocytes and Huh-7.5 cells revealed that the cell-virion combination is determinant of the entry process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942559      PMCID: PMC2224376          DOI: 10.1128/JVI.01443-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Use of long-term cultures of human hepatocytes to study cytochrome P450 gene expression.

Authors:  Lydiane Pichard-Garcia; Sabine Gerbal-Chaloin; Jean-Bernard Ferrini; Jean-Michel Fabre; Patrick Maurel
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

2.  Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor.

Authors:  S Wünschmann; J D Medh; D Klinzmann; W N Schmidt; J T Stapleton
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  CD81 engineered with endocytotic signals mediates HCV cell entry: implications for receptor usage by HCV in vivo.

Authors:  Yee-Joo Tan; Siew-Pheng Lim; Patrick Ng; Phuay-Yee Goh; Seng Gee Lim; Y H Tan; Wanjin Hong
Journal:  Virology       Date:  2003-04-10       Impact factor: 3.616

4.  Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes.

Authors:  Lionel Drocourt; Jean-Claude Ourlin; Jean-Marc Pascussi; Patrick Maurel; Marie-José Vilarem
Journal:  J Biol Chem       Date:  2002-05-03       Impact factor: 5.157

5.  DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2.

Authors:  Pierre-Yves Lozach; Hugues Lortat-Jacob; Agnès de Lacroix de Lavalette; Isabelle Staropoli; Steven Foung; Ali Amara; Corinne Houles; Frank Fieschi; Olivier Schwartz; Jean-Louis Virelizier; Fernando Arenzana-Seisdedos; Ralf Altmeyer
Journal:  J Biol Chem       Date:  2003-02-27       Impact factor: 5.157

6.  Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro.

Authors:  Valérie Castet; Chantal Fournier; Alexandre Soulier; Rozenn Brillet; Joliette Coste; Dominique Larrey; Daniel Dhumeaux; Patrick Maurel; Jean-Michel Pawlotsky
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  Characterization of low- and very-low-density hepatitis C virus RNA-containing particles.

Authors:  P André; F Komurian-Pradel; S Deforges; M Perret; J L Berland; M Sodoyer; S Pol; C Bréchot; G Paranhos-Baccalà; V Lotteau
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  Role of N glycosylation of hepatitis B virus envelope proteins in morphogenesis and infectivity of hepatitis delta virus.

Authors:  Camille Sureau; Chantal Fournier-Wirth; Patrick Maurel
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

9.  Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.

Authors:  Xiao-Feng Qin; Dong Sung An; Irvin S Y Chen; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-23       Impact factor: 11.205

10.  The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Authors:  Elisa Scarselli; Helenia Ansuini; Raffaele Cerino; Rosa Maria Roccasecca; Stefano Acali; Gessica Filocamo; Cinzia Traboni; Alfredo Nicosia; Riccardo Cortese; Alessandra Vitelli
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

View more
  51 in total

Review 1.  Tight junctions in the testis: new perspectives.

Authors:  Dolores D Mruk; C Y Cheng
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-05-27       Impact factor: 6.237

2.  Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line.

Authors:  Sibylle Haid; Marc P Windisch; Ralf Bartenschlager; Thomas Pietschmann
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

Review 3.  Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain.

Authors:  Ali Sabahi; Susan L Uprichard; William C Wimley; Srikanta Dash; Robert F Garry
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

4.  Hepatoma cell density promotes claudin-1 and scavenger receptor BI expression and hepatitis C virus internalization.

Authors:  Anne K Schwarz; Joe Grove; Ke Hu; Christopher J Mee; Peter Balfe; Jane A McKeating
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

5.  Novel function of CD81 in controlling hepatitis C virus replication.

Authors:  Yong-Yuan Zhang; Bai-Hua Zhang; Koji Ishii; T Jake Liang
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

6.  Egress of HSV-1 capsid requires the interaction of VP26 and a cellular tetraspanin membrane protein.

Authors:  Lei Wang; Longding Liu; Yanchun Che; Lichun Wang; Li Jiang; Chenghong Dong; Ying Zhang; Qihan Li
Journal:  Virol J       Date:  2010-07-14       Impact factor: 4.099

7.  Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAs.

Authors:  Saba Khaliq; Shah Jahan; Bushra Ijaz; Waqar Ahmad; Sultan Asad; Asim Pervaiz; Baila Samreen; Mahwish Khan; Sajida Hassan
Journal:  Virol J       Date:  2010-11-13       Impact factor: 4.099

8.  A novel small molecule inhibitor of hepatitis C virus entry.

Authors:  Carl J Baldick; Michael J Wichroski; Annapurna Pendri; Ann W Walsh; Jie Fang; Charles E Mazzucco; Kevin A Pokornowski; Ronald E Rose; Betsy J Eggers; Mayla Hsu; Weixu Zhai; Guangzhi Zhai; Samuel W Gerritz; Michael A Poss; Nicholas A Meanwell; Mark I Cockett; Daniel J Tenney
Journal:  PLoS Pathog       Date:  2010-09-02       Impact factor: 6.823

9.  Combined antiviral activity of interferon-alpha and RNA interference directed against hepatitis C without affecting vector delivery and gene silencing.

Authors:  Qiuwei Pan; Scot D Henry; Herold J Metselaar; Bob Scholte; Jaap Kwekkeboom; Hugo W Tilanus; Harry L A Janssen; Luc J W van der Laan
Journal:  J Mol Med (Berl)       Date:  2009-04-30       Impact factor: 4.599

Review 10.  Hepatitis C Virus entry: the early steps in the viral replication cycle.

Authors:  Ali Sabahi
Journal:  Virol J       Date:  2009-07-30       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.